The back story. Merck shares (ticker: MRK) are up 7.6% year to date, far less than the S&P 500, but it isn’t a bad showing. This has been a difficult year for health care and pharmaceutical stocks, …

More Merck and Pfizer Stocks Are on a Roll as Earnings Beat Forecasts, Raise Hope About Big Pharma Videos